Zhejiang Garden Biopharmaceutical Hits Day High with 8.96% Surge

Zhejiang Garden Biopharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 8.96% on June 30, 2026. The stock reached an intraday high of CNY 22.66, reflecting a strong day of trading activity. Over the past week, the company's stock has risen by 4.99%, outperforming the China Shanghai Composite, which saw a decline of 0.29%. In a broader context, Zhejiang Garden Biopharmaceutical has shown impressive growth over the past month, with a remarkable increase of 78.84%, compared to the China Shanghai Composite's modest gain of 0.63%. Year-to-date, the stock has risen by 44.78%, significantly outpacing the composite index's 3.16% increase. Despite these short-term gains, the company faces challenges in long-term growth metrics, with net sales growing at an annual rate of 11.18% and operating profit at 3.71% over the last five years. The current market capitalization stands at CNY 5,774 million, and the stock carries a price-to-earnings ratio of 23.00, alongside a dividend yield of 1.08%.